SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,155 | +6.5% | 26,026 | +0.6% | 0.01% | +11.1% |
Q2 2023 | $2,962 | -20.4% | 25,866 | -4.1% | 0.01% | -30.8% |
Q1 2023 | $3,719 | +6.9% | 26,985 | +0.5% | 0.01% | 0.0% |
Q4 2022 | $3,480 | -99.9% | 26,854 | +1.9% | 0.01% | +8.3% |
Q3 2022 | $2,913,000 | +55.9% | 26,348 | +5.7% | 0.01% | +50.0% |
Q2 2022 | $1,869,000 | -11.9% | 24,932 | -8.2% | 0.01% | 0.0% |
Q1 2022 | $2,121,000 | -7.6% | 27,150 | +6.5% | 0.01% | -11.1% |
Q4 2021 | $2,296,000 | +0.2% | 25,494 | +2.9% | 0.01% | 0.0% |
Q3 2021 | $2,291,000 | +22.1% | 24,770 | +2.6% | 0.01% | 0.0% |
Q2 2021 | $1,876,000 | +28.4% | 24,136 | +23.1% | 0.01% | +12.5% |
Q1 2021 | $1,461,000 | -58.1% | 19,609 | -4.1% | 0.01% | -60.0% |
Q4 2020 | $3,485,000 | +103.2% | 20,441 | +67.4% | 0.02% | +81.8% |
Q3 2020 | $1,715,000 | -9.0% | 12,210 | +3.9% | 0.01% | -15.4% |
Q2 2020 | $1,884,000 | +45.5% | 11,749 | -11.2% | 0.01% | +18.2% |
Q1 2020 | $1,295,000 | -26.1% | 13,235 | -2.6% | 0.01% | -8.3% |
Q4 2019 | $1,753,000 | – | 13,587 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |